256 related articles for article (PubMed ID: 21115718)
1. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.
Muralinath M; Kuehn MJ; Roland KL; Curtiss R
Infect Immun; 2011 Feb; 79(2):887-94. PubMed ID: 21115718
[TBL] [Abstract][Full Text] [Related]
2. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
Xin W; Li Y; Mo H; Roland KL; Curtiss R
Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.
Kang HY; Srinivasan J; Curtiss R
Infect Immun; 2002 Apr; 70(4):1739-49. PubMed ID: 11895935
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
5. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
Kong Q; Liu Q; Roland KL; Curtiss R
Infect Immun; 2009 Dec; 77(12):5572-82. PubMed ID: 19805538
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
7. Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.
Kuipers K; Jong WSP; van der Gaast-de Jongh CE; Houben D; van Opzeeland F; Simonetti E; van Selm S; de Groot R; Koenders MI; Azarian T; Pupo E; van der Ley P; Langereis JD; Zomer A; Luirink J; de Jonge MI
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28717032
[TBL] [Abstract][Full Text] [Related]
8. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
9. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae.
Nayak AR; Tinge SA; Tart RC; McDaniel LS; Briles DE; Curtiss R
Infect Immun; 1998 Aug; 66(8):3744-51. PubMed ID: 9673257
[TBL] [Abstract][Full Text] [Related]
10. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.
Bosarge JR; Watt JM; McDaniel DO; Swiatlo E; McDaniel LS
Infect Immun; 2001 Sep; 69(9):5456-63. PubMed ID: 11500417
[TBL] [Abstract][Full Text] [Related]
11. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
[TBL] [Abstract][Full Text] [Related]
12. Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization.
Kuipers K; Daleke-Schermerhorn MH; Jong WS; ten Hagen-Jongman CM; van Opzeeland F; Simonetti E; Luirink J; de Jonge MI
Vaccine; 2015 Apr; 33(17):2022-9. PubMed ID: 25776921
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal surface protein A is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis.
Swiatlo E; King J; Nabors GS; Mathews B; Briles DE
Infect Immun; 2003 Dec; 71(12):7149-53. PubMed ID: 14638806
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
Miyaji EN; Dias WO; Tanizaki MM; Leite LC
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.
Shi H; Wang S; Curtiss R
Clin Vaccine Immunol; 2013 Jun; 20(6):931-44. PubMed ID: 23616408
[TBL] [Abstract][Full Text] [Related]
16. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
[TBL] [Abstract][Full Text] [Related]
17. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization with pneumococcal surface protein A in mice.
Nagano H; Kawabata M; Sugita G; Tsuruhara A; Ohori J; Jimura T; Miyashita K; Kurono Y; Tomonaga K; Briles DE; Fujihashi K
Laryngoscope; 2018 Mar; 128(3):E91-E96. PubMed ID: 29226330
[TBL] [Abstract][Full Text] [Related]
19. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
